- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
KANJINTI - 420mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FD01 | BioTech | Trastuzumab - 420mg | 10044 | 140319/1 | KANJINTI | 420mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | 79,305,881 L.L | 2.44 | E2 | Amgen Europe BV | The Netherlands | 2/5/2024 | 0 |